Viewing Study NCT00333294


Ignite Creation Date: 2025-12-25 @ 1:32 AM
Ignite Modification Date: 2025-12-25 @ 11:45 PM
Study NCT ID: NCT00333294
Status: COMPLETED
Last Update Posted: 2007-12-19
First Post: 2006-06-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase II Iressa + Irradiation Followed by Chemo in NSCLC
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module